Jared Barsky

Array ( [id] => 7712059 [patent_doc_number] => 20120004263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Compounds for the treatment of pathologies associated with aging and degenerative disorders' [patent_app_type] => utility [patent_app_number] => 12/930702 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 12872 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496569 [patent_doc_number] => 08735384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Amino heteroaryl compounds as beta-secretase modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 13/522823 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43913 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102729 [patent_doc_number] => 20110166222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'VITAMIN C COMPOSITION FOR USE IN THE PREVENTION AND TREATMENT OF STRETCH MARKS, RADIATION DERMATITIS, AND OTHER SKIN CONDITIONS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/985098 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6895 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166222.pdf [firstpage_image] =>[orig_patent_app_number] => 12985098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660168 [patent_doc_number] => 20130040998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'FLUORINATED HDAC INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/520650 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20425 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830117 [patent_doc_number] => 20130131161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/518471 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 43238 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697881 [patent_doc_number] => 20130059890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/516943 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762428 [patent_doc_number] => 08846754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Azeotrope-like compositions of cis-1,1,1,4,4,4-hexafluoro-2-butene' [patent_app_type] => utility [patent_app_number] => 12/967522 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10793 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12967522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638243 [patent_doc_number] => 20130030046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'USE OF BLACK SOYBEAN HULL EXTRACTS IN MANUFACTURE OF PRODUCTS FOR PREVENTING AND TREATING OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 13/576748 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313617 [patent_doc_number] => 20120190637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/129108 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6753 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12226605 [patent_doc_number] => 09913832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-13 [patent_title] => 'Accelerating thrombus resolution through augmentation of p53 activity' [patent_app_type] => utility [patent_app_number] => 13/501278 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4481 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10129164 [patent_doc_number] => 09162987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 13/498036 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13551 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405489 [patent_doc_number] => 20120237552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments' [patent_app_type] => utility [patent_app_number] => 13/393458 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16397 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8612705 [patent_doc_number] => 20130018018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'NOVEL NUCLEOSIDE PHOSPHONATES AND ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/391145 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25695 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227282 [patent_doc_number] => 20120141491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCERS AND PATHOGENIC INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/389476 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5473 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11197217 [patent_doc_number] => 09427413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Uses of hypoxia-inducible factor inhibitors' [patent_app_type] => utility [patent_app_number] => 13/513659 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 18 [patent_no_of_words] => 14519 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158344 [patent_doc_number] => 20120100105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 13/381556 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8000 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100105.pdf [firstpage_image] =>[orig_patent_app_number] => 13381556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323517 [patent_doc_number] => 20120195929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'COMPOUNDS THAT MODULATE AUTOIMMUNITY AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/376119 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11917 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937441 [patent_doc_number] => 08987242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Morpholinone compounds as factor IXA inhibitors' [patent_app_type] => utility [patent_app_number] => 12/791464 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 187065 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12791464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054554 [patent_doc_number] => 20110110914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS' [patent_app_type] => utility [patent_app_number] => 12/777902 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 91233 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110914.pdf [firstpage_image] =>[orig_patent_app_number] => 12777902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148717 [patent_doc_number] => 20110020312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS' [patent_app_type] => utility [patent_app_number] => 12/778054 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 65477 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020312.pdf [firstpage_image] =>[orig_patent_app_number] => 12778054 [rel_patent_id] =>[rel_patent_doc_number] =>)